Biological role of NHERF1 protein expression in breast cancer

Histopathology

Volumn 55, Issue 5, 2009, Pages 600-608

  Mangia, Anita ^a   Chiriatti, Annalisa ^a   Bellizzi, Antonia ^a   Malfettone, Andrea ^a   Stea, Baldassarre ^a   Zito, Francesso Alfredo ^a   Reshkin, Stephen Joel ^b   Simone, Giovanni ^a   Paradiso, Angelo ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Breast cancer; HER2neu; Immunofluorescence; Immunohistochemistry; NHERF1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM STAGING; PHOSPHOPROTEINS; RECEPTOR, ERBB-2; SODIUM-HYDROGEN ANTIPORTER; TUMOR MARKERS, BIOLOGICAL;

EID: 71049145264     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03424.x     Document Type: Article

References (32)

1. Dai JL, Wang L, Sahin AA et al. NHERF (Na+H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 2004 23 8681 8687.
2. Reczek D, Berryman M, Bretscher A. Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J. Cell Biol. 1997 139 169 179.
3. Weinman EJ, Steplock D, Wang Y, Shenolikar S. Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)H(+) exchanger regulatory factor potentiates receptor activity. Mol. Cell. Biol. 2000 20 8352 8363.
4. Shenolikar S, Voltz JW, Cunningham R et al. Regulation of ion transport by the NHERF family of PDZ proteins. Physiology 2004 19 362 369.
5. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 1999 401 286 290.
6. Maudsley S, Zamah AM, Rahman N et al. Platelet-derived growth factor receptor association with Na(+)H(+) exchanger regulatory factor potentiates receptor activity. Mol. Cell. Biol. 2000 20 8352 8363.
7. Weinman EJ, Steplock D, Wade JB et al. Ezrin binding domain-deficient NHERF attenuates cAMP-mediated inhibition of Na(+)H(+) exchange in OK cells. Am. J. Physiol. 2001 281 F374 F380.
8. Lazar CS, Cresson CM, Lauffenburger DA et al. The Na+H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol. Biol. Cell 2004 15 5470 5480.
9. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP et al. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am. J. Pathol. 2001 158 57 62.
10. Fouassier L, Duan CY, Feranchak AP et al. Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 2001 33 166 176.
11. Shibata T, Chuma M, Kokubu A et al. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003 38 178 186.
12. Fraenzer JT, Pan H, Minimo L et al. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation. Int. J. Oncol. 2003 23 1493 1500.
13. Cardone RA, Bellizzi A, Busco G et al. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol. Biol. Cell 2007 18 1768 1780.
14. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin- binding phosphoprotein 50 in breast cancer. Histopathology 2007 51 40 53. (Pubitemid 46976376)
15. Cardone RA, Bagorda A, Bellizzi A et al. Protein kinase A gating of a pseudopodial-located RhoAROCKp38NHE1 signal module regulates invasion in breast cancer cell lines. Mol. Biol. Cell 2005 16 3117 3127.
16. Cardone RA, Casavola V, Reshkin SJ. The role of disturbed pH dynamics and the Na+H+ exchanger in metastasis. Nat. Rev. Cancer 2005 5 786 795.
17. Hermanek P, Sobin LH eds. UICC TNM: classification of malignant tumours, 4th edn. New York : John Wiley & Sons, Inc., 1988.
18. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 2002 41 151.
19. Holland R, Peterse JL, Millis RR et al. Ductal carcinoma in situ: a proposal for a new classification. Semin. Diagn. Pathol. 1994 11 167 180.
20. Paradiso A, Mangia A, Chiriatti A et al. Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer. Ann. Oncol. 2005 16 iv14 iv19.
21. Ediger TR, Kraus WL, Weinman EJ et al. Estrogen receptor regulation of the Na+H+ exchange regulatory factor. Endocrinology 1999 140 2976 2982.
22. Inouye T, Inokuchi M, Shimizu K, Abe K. Interstitial vascular reaction of naturally occurring mammary adenocarcinoma in old C3HHeJ female mice. Jikken Dobutsu 1984 33 151 157.
23. Favaro E, Nardo G, Persano L et al. Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. Am. J. Pathol. 2008 173 1186 1201.
24. Takahashi Y, Morales FC, Kreimann EL et al. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signalling. EMBO J. 2006 25 910 920.
25. Kreimann EL, Morales FC, de Orbeta-Cruz J et al. Cortical stabilization of beta-catenin contributes to NHERF1EBP50 tumor suppressor function. Oncogene 2007 26 5290 5299.
26. Guo W, Pylayeva Y, Pepe A et al. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006 126 489 502.
27. Gschwind A, Fischer OM, Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 2004 4 361 370. (Pubitemid 38579482)
28. Aranda V, Haire T, Nolan ME et al. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat. Cell Biol. 2006 8 1235 1245.
29. Ivkovic-Kapicl T, Knezevic-Usaj S, Djilas-Ivanovic D et al. Correlation of HER-2neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer. In Vivo 2007 21 673 678. (Pubitemid 47232671)
30. Weinman EJ, Hall RA, Friedman PA et al. The association of NHERF adaptor proteins with g protein-coupled receptors and receptor tyrosine kinases. Annu. Rev. Physiol. 2006 68 491 505. Review.
31. Pan Y, Weinman EJ, Dai JL. Na+H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res. 2008 10 R5.
32. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 2005 5 591 602. Review.